Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
110
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 120 publications
(116 citation statements)
references
References 34 publications
5
110
1
Order By: Relevance
“…The benefit of “what you see is what you get” from ROSE smears predicts NGS success, and therefore allows a simple workflow combining primarily the smears and then the cell blocks. ROSE itself improves the overall ability for the EBUS-TBNA procedure as a whole to provide NGS material [40]. …”
Section: Discussionmentioning
confidence: 99%
“…The benefit of “what you see is what you get” from ROSE smears predicts NGS success, and therefore allows a simple workflow combining primarily the smears and then the cell blocks. ROSE itself improves the overall ability for the EBUS-TBNA procedure as a whole to provide NGS material [40]. …”
Section: Discussionmentioning
confidence: 99%
“…Onsite pathology advice reduces unnecessary TBNA when sufficient tissue has been obtained for diagnosis and all ancillary tests. More importantly this advice helps avoid repeat procedures for more tissue (16,17).…”
Section: Discussionmentioning
confidence: 99%
“…These authors provided guidelines for specimen acquisition and preparation, indicating that ROSE does not modify EBUS-TBNA diagnostic yield, nor does it affect the number of needle passes, the duration of the procedure, and the complication rate. However, when EBUS-TBNA was the first diagnostic procedure in patients with suspect lung cancer, ROSE was found to reduce the number of additional procedures (25,26).…”
Section: Sample Acquisition and Preparation Techniquesmentioning
confidence: 99%
“…The success in performing molecular tests on TBNA samples depends on the absolute number and percentage of malignant cells present in the sampled material, on quality of cell preservation and on type and sensitivity of the test itself (17,39). Recent reports from high-volume centers indicate that 72-97% of EBUS-TBNA samples are appropriate for testing the most frequently used prognostic markers of lung cancer, namely EGFR, ALK and KRAS (17,25,39,40). Both smear and cell block preparation, or core tissue, can be utilized for molecular testing (17,23); however, while EGFR and KRAS status can be determined using all three specimen preparation techniques, the ALK translocation is best assessed using cell block and core tissue (17).…”
Section: Molecular Testingmentioning
confidence: 99%
See 1 more Smart Citation